Results 191 to 200 of about 690,479 (320)
Hepatocellular carcinoma in patients without cirrhosis. [PDF]
Sato-Espinoza K+3 more
europepmc +1 more source
Clinical course on patients with primary hepatocellular carcinoma surviving longer than one year.
Mikio Nishioka+16 more
openalex +2 more sources
Alterations in arginine metabolism and β‐hydroxybutyrylation (Kbhb) modifications play a critical role in tumor progression. This study reveals valuable insights into arginine metabolism reprogramming involving the ARG1‐Kbhb/P300/SLC3A2 signaling axis and uncovers an effective therapy combining BHB with ARG1 inhibitor through conventional enzymatic and
Chuman Lin+6 more
wiley +1 more source
The role of GALAD score in the surveillance of hepatocellular carcinoma. [PDF]
İstemihan Z+15 more
europepmc +1 more source
Hepatocellular carcinoma in the U.S.A., etiologic considerations
Masao Omata+3 more
openalex +1 more source
Androgen and estrogen receptors in hepatocellular carcinoma and in the surrounding noncancerous liver tissue [PDF]
S. Tsuyoshi Ohnishi+4 more
openalex +1 more source
ID1 is regulated by E3 ligase TRIM21, which adds non‐degradative K11‐linked ubiquitin at Lys91, disrupting ID1‐TCF12 binding and freeing TCF12 to upregulate copper transporter SLC31A1. Enhanced SLC31A1 elevates intracellular copper, triggers cuproptosis, and inhibits ESCC growth.
Lei Li+6 more
wiley +1 more source
Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinoma. [PDF]
Xu W+12 more
europepmc +1 more source
Ultrastructure of Human Hepatocellular Carcinoma-Fine Structure of Blood Spaces (Tumor Vessels)
Tadashi Isomura
openalex +2 more sources
Establishment of a cell line from a woodchuck hepatocellular carcinoma [PDF]
Masashi Unoura+9 more
openalex +1 more source